KOTAI Biotechnologies, Inc

Visit website

About the employer

The repertoire of immune cell receptors has direct consequences for resistance to infection, autoimmune disease and cancer.

KOTAI’s platform technology can reveal the structure and function of immune cell receptors with unprecedented resolution from a routine blood sample.

Our vision is to provide technology that reveals the functional state of the immune system at the molecular level.

The only high-throughput structural modeling and analysis platform for immune cell sequences.

    Our B and T cell receptor modeling technology is the most accurate available. Typical errors for backbone residues is less than 1 Angstrom.
    The current version of Repertoire Builder produces 1,000 models per day on a single processor, and scales linearly with the number of processors.
    Using sequence and structural features from B or T cell receptor models, Repertoire Builder can group receptors according to their target epitopes, revealing the functional landscape of a donor and quantifying differences between donors.

Employer location

Discover similar employers

DISCO International Ltd Tokyo, Japan 0 open positions
PricewaterhouseCoopers (PwC) Tokyo, Japan 0 open positions
Prefectural University of Hiroshima Hiroshima, Japan 0 open positions
Astellas Pharma Group Higashimurayama, Japan 0 open positions
Kyoto University Kyoto, Japan 0 open positions
More employers